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1. Introduction 
It has been reported that /3-cyclopiazonate oxido- 
cyclase from Penicillium cyclopium, an enzyme 
which catalyzes the dehydrogenation and cyclization 
of P-cyclopiazonic to a-cyclopiazonic acid, contains 
covalently bound flavin [I] . A flavin peptide, 
rele: sed by digestion with pronase has been partially 
purified and preliminary results suggested that the 
flavin is at the dinucleotide level. The present paper 
is the first report of a collaborative study between 
the laboratories in South Africa and in San Francisco, 
aimed at defining the structure of the flavin site of 
this enzyme. It has been found that the flavin is 
attached to the protein by way of the 8 (Y group, as 
in other enzymes containing covalently bound 
flavin [2] and that the amino acid substituent is 
histidine, as in succinate dehydrogenase [3,4] but 
the nature of the linkage of the flavin to the imidazole 
is different from that in succinate dehydrogenase. 
The unusual properties of the flavin peptide from 
North-Holland Publishing Company - Amsterdam 
/3-cyclopiazonate oxidocyclase appear to be in part 
due to the covalently bound histidine, in part to 
non-covalent interaction between the flavin and 
other aminoacyl residues within the peptide. 
2. Materials and methods 
/3-Cyclopiazonate oxidocyclase was purified as in 
previous work [5]. After removal of acid-extractable 
flavins with trichloroacetic acid, flavin peptides were 
released by digestion with tripsin-chymotrypsin 
(0.1 mg each per mg of protein, 4 hr, 38”C, pH 8). 
A tryptic-chymotryptic peptide was then purified 
by chromatography on Florisil and cellulose phos- 
phate columns. Corrected fluorescence spectra were 
recorded with a Hitachi-Perkin Elmer MPF-3 
spectrofluorometer. 
3. Results and discussion 
The fluorescence excitation spectrum of the 
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Fig. 1. Corrected fluorescence xcitation spectra of tryptic- 
chymotryptic flavin peptide at pH 3.4 before and after 
oxidation with performic acid at Ok. 
purified flavin peptide from P-cyclopiazonate oxido- 
cyclase, at the monophosphate level (fig. I), differs 
from the corresponding spectrum of FMN in two 
important respects. First, the 372 nm band is hypso- 
chromically shifted to 348 mn, indicative of 8a( 
substitution, as in other flavin peptides [2,6-81. 
Second, the fluorescence is extensively quenched at 
pH 3.4, relative to FMN, but increases nearly three- 
fold on oxidation with performic acid at 0” (table 1, 
fig. 2). Similar increase in fluorescence upon 
oxidation with performic acid has been seen in other 
flavin peptides, which contain an oxidizable group 
substituted on, or interacting with, the flavin, as in 
the case of cysteinyl flavin thioether from mono- 
amine oxidase [9] and cysteinyl flavin thiohemiacetal 
from Chromatium cytochrome css2 [lO,ll]. 
Unlike in those flavin peptides, however, the 
second fluorescence excitation maximum does not 
shift significantly on oxidation with performic acid 
(fig. 1). 
A third difference from FMN and riboflavin is 
illustrated in fig. 2, which shows that the fluorescence 
is further quenched on neutralization of the flavin 
peptide, both before and after oxidation with per- 
Fig. 2. pH-fluorescence profile of tryptic-chymotryptic 
flavin peptide (FMN level). (O), before performic acid 
oxidation; (e), after performic acid oxidation at O’C. 
Fluorescence is percent relative to riboflavin assuming 
X4se = 12 000 for flavin peptide. 
formic acid. The PK, of this fluorescence quenching 
(5.8, table l), is more than one pH unit higher, how- 
ever, than in ZV(3)histidyl flavin peptides from 
succinate dehydrogenase [4] or D-6-hydroxynicotine 
oxidase [ 121. 
Since the foregoing results bear evidence both for 
the presence of a substituent containing a secondary 
or tertiary nitrogen on the flavin and for a readily 
oxidizable group in the flavin peptide, the latter was 
Table 1 
pK, of fluorescence quenching 
Flavin Fluorescence* pKa 
w’) 
Tryptic-chymotryptic peptide 
after pyrophosphatase 19 5.4 
Same after performic acid 
oxidation at O°C 59 5.8 
Amino acyl flavin** 100*** 5.0 
Same after performic acid 
oxidation at Ok 100*** 4.9 
* Relative to riboflavin = 100; pH 3.4. 
** 6 N HCl, 9S°C, 17 hr. Purification by thin-layer 
chromatography. 
*** Estimated after consideration of loss due to acid 
hydrolysis and recovery from thin-layer chromatography. 
Actual yield = 48%. 
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Fig. 3. pH-fluorescence curve of amino acyl flavin. The 
flavin peptide was hydrolyzed in 6 N HCI at 95% for 17 hr 
and the ammoacyl flavin was isolated by thin-layer 
chromatography. 
subjected to acid hydrolysis (6 N HCl, 95”C, 17 hr) in 
order to cleave all amino acids except that substi- 
tuted on the flavin and thereby distinguish between 
effects involving direct substitution of the 8cr group 
and those involving interaction between the flavin 
and amino acids in the peptide. 
Fig. 3 presents the dependence of the fluorescence 
yield on pH of the acid-hydrolyzed tryptic-chymo- 
tryptic flavin peptide. The characteristic fluorescence 
quenching in the range of 3.2-8.0 is retained, with a 
pKa of 5.0 * 0.1 before (fig. 3) and 4.9 after (table 1) 
performic acid oxidation. The fluorescence yield, 
however, was not materially altered by performic acid 
oxidation of the aminoacyl flavin. It seems clear, 
therefore, that the pH dependence of the fluorescence 
is a function of the amino acid immediately sub- 
stituted on the flavin, whereas the action of performic 
acid in increasing the fluorescence yield involves an 
interacting amino acid within the peptide. 
The aminoacyl flavin, derived by acid hydrolysis 
of the tryptic-chymotryptic peptide, gives a positive 
ninhydrin test, a negative Pauly reaction and differs 
both in the pK, of fluorescence quenching and in 
mobility on high voltage electrophoresis at pH 5.0 
(being more cationic) from both N( 1) and N(3)- 
histidylriboflavin. Its properties appear to coincide, 
however, with those of the acid-hydrolyzed amino 
acyl flavin recently isolated from thiamine dehydro- 
genase [ 131. As in the case of the latter, drastic acid 
hydrolysis (125°C 6 N HCI, 16 hr) liberates histidine, 
which has been identified by its mobility in TLC 
(Eastman # 13255 cellulose plates, butanol: acetic 
acid : H,O, 4: 1: 5, upper phase) and by a positive 
Pauly reaction. Thus, as in the amino acyl flavin 
from thiamine dehydrogenase, also in /3-cyclopiazonate 
oxidocyclase the flavin appears to be linked to the 
imidazole ring of histidine, because the Pauly 
reaction is negative before drastic acid hydrolysis. 
Current studies [ 141 in this laboratory on a synthetic 
histidyl-flavin adduct, which appears to be identical 
with the amino acyl flavin derived from /I-cyclopia- 
zonate oxidocyclase, suggest hat an imidazole 
nitrogen is the site of attachment but that it is not 
a condensation product of histidine with 8-hydroxy- 
riboflavin as found in succinate dehydrogenase. 
From analogy with previous studies on the peptic 
peptide of Chromatium cytochrome cs52 [ 111, it is 
anticipated that an aromatic acyl residue in the 
tryptic-chymotryptic peptide is responsible for the 
major increase in fluorescence after oxidation with 
performic acid. Establishment of the nature of this 
effect will have to await further purification of the 
peptide and the determination of its amino acid 
composition and sequence. 
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